Biologic agents, such as TNF inhibitors, are a mainstay in the treatment of RA and other inflammatory conditions, such as inflammatory bowel disease or psoriasis, offering significant therapeutic benefits [1,4]. This evidence concerns the gene TNF and rheumatoid arthritis.